申请人:——
公开号:US20010039283A1
公开(公告)日:2001-11-08
Novel compounds of the formula:
1
or a pharmaceutically acceptable salt or solvate thereof, wherein:
a represents N or NO
−
;
R
1
and R
3
are the same or different and each represents halo;
R
2
and R
4
are the same or different and each is selected from H and halo, provided that at least one of R
2
and R
4
is H;
T is a substituent selected from SO
2
R or
2
Z is O or S;
n is zero or an integer from 1 to 6;
R is alkyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, cycloalkyl, heterocycloalkyl, or N(R
5
)
2
;
R
5
is H, alkyl, aryl, heteroaryl or cycloalkyl.
Also disclosed are methods of inhibiting farnesyl protein transferase and methods for treating tumor cells.
式中的新型化合物:
1
或其药学上可接受的盐或溶液,其中
a 代表 N 或 NO
-
;
R
1
和 R
3
相同或不同,各自代表卤代烃;
R
2
和 R
4
相同或不同,且各自选自 H 和卤代,条件是 R
2
和 R
4
为 H;
T 是选自 SO
2
R 或
2
Z 是 O 或 S
n 为零或 1-6 的整数;
R 是烷基、芳基、芳烷基、杂芳基、杂芳烷基、环烷基、杂环烷基或 N(R
5
)
2
;
R
5
是 H、烷基、芳基、杂芳基或环烷基。
还公开了抑制法呢基蛋白转移酶的方法和治疗肿瘤细胞的方法。